Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis RGEN

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History RGEN

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years 0
Forward Annual Dividend – USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends 0
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.
Dividend Policy i

Sales Growth RGEN

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin RGEN

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income RGEN

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM RGEN

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio RGEN

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Repligen Corporation RGEN

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself RGEN

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 154.39
Forward PE 71.43
Enterprise Value Revenue 10.33
Price Sales TTM 10.15
Enterprise Value EBITDA 44.69
Price Book MRQ 3.79

Repligen Corporation

RGEN
Current price
144.24 USD +0.3 USD (+0.21%)
Last closed 137.41 USD
ISIN US7599161095
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 7 750 987 776 USD
Yield for 12 month +18.88 %
1Y
3Y
5Y
10Y
15Y
RGEN
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+738 256 000 USD

Last Year

+634 439 000 USD

Current Quarter

+194 255 000 USD

Last Quarter

+197 913 000 USD

Current Year

+347 624 000 USD

Last Year

+274 645 000 USD

Current Quarter

+98 484 000 USD

Last Quarter

+93 443 000 USD
EBITDA 134 236 992 USD
Operating Margin TTM 8.90 %
Price to Earnings 154.39
Return On Assets TTM 1.18 %
PEG Ratio 2.23
Return On Equity TTM 2.51 %
Wall Street Target Price 177.05 USD
Revenue TTM 763 339 008 USD
Book Value 37.33 USD
Revenue Per Share TTM 13.56 USD
Dividend Share
Quarterly Revenue Growth YOY 14.80 %
Dividend Yield
Gross Profit TTM 405 624 992 USD
Earnings per share 0.89 USD
Diluted Eps TTM 0.89 USD
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY 47.90 %
Profit Margin 6.73 %
Price to Free Cash Flow TTM 77.97

Technical Indicators RGEN

For 52 Weeks

100.99 USD 175.77 USD
50 Day MA 124.49 USD
Shares Short Prior Month 5 962 038
200 Day MA 139.32 USD
Short Ratio 5.10
Shares Short 5 726 265
Short Percent 10.18 %